Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction.

作者: Zhiqiang Pei , Dengfeng Ma , Lei Ji , Jing Zhang , Jinsheng Su

DOI: 10.1016/J.PEPTIDES.2014.02.016

关键词:

摘要: … of in-hospital malignant arrhythmia and other adverse cardiac … Malignant arrhythmia and other major adverse cardiac … the influence factors of malignant arrhythmia and other MACE …

参考文章(24)
Lin Liu, Wenhui Ding, Renxu Li, Xiaojin Ye, Jing Zhao, Jie Jiang, Lei Meng, Jie Wang, Songyun Chu, Xiaoning Han, Fen Peng, Plasma levels and diagnostic value of catestatin in patients with heart failure Peptides. ,vol. 46, pp. 20- 25 ,(2013) , 10.1016/J.PEPTIDES.2013.05.003
Andrea H. Gaede, Mandy S.Y. Lung, Paul M. Pilowsky, Catestatin attenuates the effects of intrathecal nicotine and isoproterenol. Brain Research. ,vol. 1305, pp. 86- 95 ,(2009) , 10.1016/J.BRAINRES.2009.09.088
Gjin Ndrepepa, Siegmund Braun, Julinda Mehilli, Nicolas von Beckerath, Stephan Nekolla, Wolfgang Vogt, Markus Schwaiger, Albert Schömig, Adnan Kastrati, N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. American Journal of Cardiology. ,vol. 97, pp. 1151- 1156 ,(2006) , 10.1016/J.AMJCARD.2005.11.029
Igor Tsigelny, Sushil K Mahata, Laurent Taupenot, Nicholas E Preece, Manjula Mahata, Imran Khan, Robert J Parmer, Daniel T O'Connor, Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a β-strand/loop/β-strand structure secured by hydrophobic interactions and predictive of activity Regulatory Peptides. ,vol. 77, pp. 43- 53 ,(1998) , 10.1016/S0167-0115(98)00040-8
Michael Weber, Oscar Bazzino, Jose L. Navarro Estrada, Juan J. Fuselli, Fernando Botto, Diego Perez de Arenaza, Helge Möllmann, Holger N. Nef, Albrecht Elsässer, Christian W. Hamm, N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Journal of the American College of Cardiology. ,vol. 51, pp. 1188- 1195 ,(2008) , 10.1016/J.JACC.2007.11.054
Nilima Biswas, Sucheta M. Vaingankar, Manjula Mahata, Madhusudan Das, Jiaur R. Gayen, Laurent Taupenot, Justin W. Torpey, Daniel T. O’Connor, Sushil K. Mahata, Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology. ,vol. 149, pp. 749- 757 ,(2008) , 10.1210/EN.2007-0838
S K Mahata, D T O'Connor, M Mahata, S H Yoo, L Taupenot, H Wu, B M Gill, R J Parmer, Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. Journal of Clinical Investigation. ,vol. 100, pp. 1623- 1633 ,(1997) , 10.1172/JCI119686
Lin Liu, Wenhui Ding, Feng Zhao, Libin Shi, Yongzheng Pang, Chaoshu Tang, Plasma levels and potential roles of catestatin in patients with coronary heart disease. Scandinavian Cardiovascular Journal. ,vol. 47, pp. 217- 224 ,(2013) , 10.3109/14017431.2013.794951
Sushil K. Mahata, Manjula Mahata, Maple M. Fung, Daniel T. O'Connor, Catestatin: a multifunctional peptide from chromogranin A. Regulatory Peptides. ,vol. 162, pp. 33- 43 ,(2010) , 10.1016/J.REGPEP.2010.01.006
Trygve Husebye, Jan Eritsland, Carl Müller, Leiv Sandvik, Harald Arnesen, Ingebjørg Seljeflot, Arild Mangschau, Reidar Bjørnerheim, Geir Øystein Andersen, Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study. European Journal of Heart Failure. ,vol. 15, pp. 565- 572 ,(2013) , 10.1093/EURJHF/HFS215